Condition

Psychedelics for eating disorders: what the evidence shows

Includes anorexia nervosa, bulimia and binge-eating disorder. Published psychedelic research so far is almost all in anorexia.

Last reviewed 23 October 2026Re-checked every month1 substances with published evidence

Where are these treatments legal?See country-by-country rules on our Psychedelic Therapy Legality Map

Substance by substance

One card per substance, strongest evidence first. A substance that isn’t here has no published clinical evidence for this condition yet.

Psilocybin

Early research

Two small uncontrolled studies in anorexia. Safety signals only.

In an open-label study of 10 women with anorexia, psilocybin was safe and tolerable; four had meaningful drops in eating-disorder symptoms at three months.¹

A 2026 pilot with 21 women saw eating-disorder scores fall at every follow-up, but body weight didn't change meaningfully, and there was no comparison group.²

Everything psilocybin has been tested for →

Keep reading

New Solutions for Anorexia: Expanding Conventional TherapyHow newer therapies could change recovery from one of the hardest conditions to treat.Read the article

Brain Changes After One Psilocybin TreatmentA single 25 mg dose reshaped white matter in 28 people, with changes still visible a month later.Read the article

Listen to the Body: Nervous System Coach Shares Her ToolsA nervous system coach on learning the body's signals, and the tools she shares with clients.Read the article Research databaseNew studies, summarisedHundreds of papers on psychedelics and mental health, each with a plain-language summary and key facts.Browse the database

Sources

Numbered in the order they appear above. We only use peer-reviewed papers, official company announcements (for trial status and topline results), regulators and trial registries.